Centerview Partners is an American independent investment banking firm founded in 2006 by Blair Effron and Robert Pruzan. The company is headquartered in New York City and operates with offices in London, Paris, Menlo Park, and San Francisco. Centerview Partners specializes in providing strategic advisory services, including mergers and acquisitions, financial restructurings, valuation, and capital structure advice to companies, institutions, and governments[3][5]. ### Key Features of Centerview Partners - Industry Expertise: Centerview Partners has a strong presence in various sectors, particularly in consumer and healthcare transactions[5]. - Transaction Volume: Since its inception, the firm has advised on over $3 trillion in transactions, including significant deals like the sale of Biohaven Pharmaceutical to Pfizer[3][5]. - Employee Base: The firm has approximately 60 partners and 400 professionals, although some sources indicate a slightly different employee count[3][1]. - Reputation: Centerview Partners has been recognized as the "#1 investment bank to work for" in the Vault survey for multiple years, reflecting its strong work environment and compensation[3][5]. ### Leadership and Notable Transactions - Leadership: The firm is led by experienced partners, including Blair Effron, who often discusses market trends and M&A environments[3]. - Notable Transactions: Centerview Partners has advised on numerous high-profile transactions, such as the Pfizer-Biohaven deal, showcasing its expertise in complex corporate situations[5]. ### Community Engagement Centerview Partners is committed to community involvement, with its partners actively participating in various philanthropic and educational organizations[3].